Cargando…

Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity

Antimicrobial peptides (AMPs) are a potential source of new molecules to counter the increase in antimicrobial resistant infections but a better understanding of their properties is required to understand their native function and for effective translation as therapeutics. Details of the mechanism o...

Descripción completa

Detalles Bibliográficos
Autores principales: Manzo, Giorgia, Ferguson, Philip M., Gustilo, V. Benjamin, Hind, Charlotte K., Clifford, Melanie, Bui, Tam T., Drake, Alex F., Atkinson, R. Andrew, Sutton, J. Mark, Batoni, Giovanna, Lorenz, Christian D., Phoenix, David A., Mason, A. James
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362004/
https://www.ncbi.nlm.nih.gov/pubmed/30718667
http://dx.doi.org/10.1038/s41598-018-37630-3
_version_ 1783392799741181952
author Manzo, Giorgia
Ferguson, Philip M.
Gustilo, V. Benjamin
Hind, Charlotte K.
Clifford, Melanie
Bui, Tam T.
Drake, Alex F.
Atkinson, R. Andrew
Sutton, J. Mark
Batoni, Giovanna
Lorenz, Christian D.
Phoenix, David A.
Mason, A. James
author_facet Manzo, Giorgia
Ferguson, Philip M.
Gustilo, V. Benjamin
Hind, Charlotte K.
Clifford, Melanie
Bui, Tam T.
Drake, Alex F.
Atkinson, R. Andrew
Sutton, J. Mark
Batoni, Giovanna
Lorenz, Christian D.
Phoenix, David A.
Mason, A. James
author_sort Manzo, Giorgia
collection PubMed
description Antimicrobial peptides (AMPs) are a potential source of new molecules to counter the increase in antimicrobial resistant infections but a better understanding of their properties is required to understand their native function and for effective translation as therapeutics. Details of the mechanism of their interaction with the bacterial plasma membrane are desired since damage or penetration of this structure is considered essential for AMPs activity. Relatively modest modifications to AMPs primary sequence can induce substantial changes in potency and/or spectrum of activity but, hitherto, have not been predicted to substantially alter the mechanism of interaction with the bacterial plasma membrane. Here we use a combination of molecular dynamics simulations, circular dichroism, solid-state NMR and patch clamp to investigate the extent to which temporin B and its analogues can be distinguished both in vitro and in silico on the basis of their interactions with model membranes. Enhancing the hydrophobicity of the N-terminus and cationicity of the C-terminus in temporin B improves its membrane activity and potency against both Gram-negative and Gram-positive bacteria. In contrast, enhancing the cationicity of the N-terminus abrogates its ability to trigger channel conductance and renders it ineffective against Gram-positive bacteria while nevertheless enhancing its potency against Escherichia coli. Our findings suggest even closely related AMPs may target the same bacterium with fundamentally differing mechanisms of action.
format Online
Article
Text
id pubmed-6362004
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-63620042019-02-06 Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity Manzo, Giorgia Ferguson, Philip M. Gustilo, V. Benjamin Hind, Charlotte K. Clifford, Melanie Bui, Tam T. Drake, Alex F. Atkinson, R. Andrew Sutton, J. Mark Batoni, Giovanna Lorenz, Christian D. Phoenix, David A. Mason, A. James Sci Rep Article Antimicrobial peptides (AMPs) are a potential source of new molecules to counter the increase in antimicrobial resistant infections but a better understanding of their properties is required to understand their native function and for effective translation as therapeutics. Details of the mechanism of their interaction with the bacterial plasma membrane are desired since damage or penetration of this structure is considered essential for AMPs activity. Relatively modest modifications to AMPs primary sequence can induce substantial changes in potency and/or spectrum of activity but, hitherto, have not been predicted to substantially alter the mechanism of interaction with the bacterial plasma membrane. Here we use a combination of molecular dynamics simulations, circular dichroism, solid-state NMR and patch clamp to investigate the extent to which temporin B and its analogues can be distinguished both in vitro and in silico on the basis of their interactions with model membranes. Enhancing the hydrophobicity of the N-terminus and cationicity of the C-terminus in temporin B improves its membrane activity and potency against both Gram-negative and Gram-positive bacteria. In contrast, enhancing the cationicity of the N-terminus abrogates its ability to trigger channel conductance and renders it ineffective against Gram-positive bacteria while nevertheless enhancing its potency against Escherichia coli. Our findings suggest even closely related AMPs may target the same bacterium with fundamentally differing mechanisms of action. Nature Publishing Group UK 2019-02-04 /pmc/articles/PMC6362004/ /pubmed/30718667 http://dx.doi.org/10.1038/s41598-018-37630-3 Text en © The Author(s) 2019 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Manzo, Giorgia
Ferguson, Philip M.
Gustilo, V. Benjamin
Hind, Charlotte K.
Clifford, Melanie
Bui, Tam T.
Drake, Alex F.
Atkinson, R. Andrew
Sutton, J. Mark
Batoni, Giovanna
Lorenz, Christian D.
Phoenix, David A.
Mason, A. James
Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity
title Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity
title_full Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity
title_fullStr Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity
title_full_unstemmed Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity
title_short Minor sequence modifications in temporin B cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity
title_sort minor sequence modifications in temporin b cause drastic changes in antibacterial potency and selectivity by fundamentally altering membrane activity
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6362004/
https://www.ncbi.nlm.nih.gov/pubmed/30718667
http://dx.doi.org/10.1038/s41598-018-37630-3
work_keys_str_mv AT manzogiorgia minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT fergusonphilipm minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT gustilovbenjamin minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT hindcharlottek minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT cliffordmelanie minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT buitamt minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT drakealexf minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT atkinsonrandrew minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT suttonjmark minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT batonigiovanna minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT lorenzchristiand minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT phoenixdavida minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity
AT masonajames minorsequencemodificationsintemporinbcausedrasticchangesinantibacterialpotencyandselectivitybyfundamentallyalteringmembraneactivity